Tang, Mei
Garg, Amit
Bonate, Peter L.
Rosenberg, Jonathan E.
Matsangou, Maria
Kadokura, Takeshi
Yamada, Akihiro
Choules, Mary
Pavese, Janet
Nagata, Masanori
Tenmizu, Daisuke
Koibuchi, Akira
Heo, Nakyo
Wang, Lu
Wojtkowski, Tomasz
Hanley, William D.
Poondru, Srinivasu http://orcid.org/0009-0002-8807-9894
Funding for this research was provided by:
National Cancer Institute Cancer Center Support (P30 CA008748)
Astellas Pharma, Inc.
Seagen Inc.
Article History
Accepted: 12 March 2024
First Online: 12 April 2024
Declarations
:
: This review was sponsored by Astellas Pharma, Inc., and Seagen, which was acquired by Pfizer in December 2023. JER is supported by in part by National Cancer Institute Cancer Center Support grant P30 CA008748.
: Mei Tang has no financial disclosures to declare. Amit Garg reports stock/stock options as an employee of Pfizer Inc. Peter L. Bonate, Takeshi Kadokura, Akihiro Yamada, Mary Choules, Janet Pavese, Akira Koibuchi, Nakyo Heo, Lu Wang, Tomasz Wojtkowski, and Srinivasu Poondru are employees of Astellas Pharma Global Development Inc. Jonathan E. Rosenberg reports consulting/advisory fees from Astellas Pharma, AstraZeneca/MedImmune, Bayer, BioClin Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Immunomedics, Infinity Pharmaceuticals, Janssen Oncology, Lilly, Merck, Mirati Therapeutics, Pfizer/EMD Serono, Pharmacyclics, QED Therapeutics, Roche/Genentech, Seagen Inc., and Tyra Biosciences; honoraria from Clinical Care Options, EMD Serono, Intellisphere, Medscape, MJH Life Sciences, PeerView, Physicians’ Education Resource, Research To Practice, and UpToDate; patents, royalties, and other intellectual property to their institution for a Predictor of Platinum Sensitivity; and institutional research funding from Astellas Pharma, AstraZeneca, Bayer, Genentech/Roche, QED Therapeutics, and Seagen Inc. Maria Matsangou, Masanori Nagata, and Daisuke Tenmizu are employees of Astellas Pharma, Inc. William D. Hanley reports stock and stock options as an employee of Pfizer Inc.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualization: MT, AG, PLB, JER, TK, AY, MC, JP, WDH, SP. Literature search: MT, AG, PLB, JER, WDH. Data analysis: AY, MC, JP, MN, DT, NH, LW, TW. Writing – original draft preparation: MT, AG, PLB, JER, MM, TK, AY, AK, MC, JP, NH, LW, TW, WDH, SP. All authors participated in the critical review and revision of this manuscript and provided approval of the manuscript for submission.